301301.SZ
川宁生物
SZSE · C 制造业 · CN
CNY 8.62
−4.43%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 25.02x
- PEG TTM
- 1.32x
- Price / book
- 2.46x
- Price / sales
- 4.24x
- Price / cash flow
- 30.45x
Enterprise value
- Enterprise value
- CNY 19.3B
- EV / sales
- 4.37x
- EV / EBITDA
- 12.61x
- EV / EBIT
- 25.86x
- Market cap
- CNY 19.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026